BACKGROUND: Interleukin (IL)-21 is the most recently described cytokine that signals via the common cytokine receptor (gammac), is produced by activated CD4+ T-cells, and regulates expansion and effector function of CD8+ T-cells. MATERIALS: To explore the actions of IL-21 with other gammac-dependent cytokines in alloreactivity, mRNA expression of IL-21, IL-21R alpha-chain, and IL-2 proliferation and cytotoxicity was measured after stimulation in mixed lymphocyte reactions. Additionally, IL-21 and IL-21R alpha-chain expression was studied in biopsies of heart transplant patients. RESULTS: Analysis of mRNA expression levels of allostimulated T-cells showed a 10-fold induction of IL-21 and IL-21R alpha-chain. Interestingly, induction of IL-21 was highly dependent on IL-2 (as in the presence of anti-IL-2, anti-IL-2R alpha-chain, and the immunosuppressive drugs cyclosporine A, tacrolimus, and rapamycin) the transcription of IL-21 was almost completely inhibited, whereas in the presence of exogenous IL-2 the mRNA expression of IL-21 was even more upregulated. IL-21 functioned as a costimulator for IL-2 to augment proliferation and cytotoxic responses, while blockade of the IL-2 route abrogated these functions of IL-21. Blockade of the IL-21 route by anti-IL-21R alpha-chain monoclonal antibodies inhibited the proliferation of alloactivated T-cells. Also, in vivo alloreactivity was associated with IL-21/IL-21R alpha-chain expression. After heart transplantation, the highest intragraft IL-21, IL-21R alpha-chain, and IL-2 mRNA expression levels were measured during acute rejection (P<0.001, P=0.01, P=0.03). CONCLUSION: IL-21 is a critical cytokine for IL-2 dependent immune processes. Blockade of the IL-21 pathway may provide a new perspective for the treatment of allogeneic responses in patients after transplantation.
BACKGROUND:Interleukin (IL)-21 is the most recently described cytokine that signals via the common cytokine receptor (gammac), is produced by activated CD4+ T-cells, and regulates expansion and effector function of CD8+ T-cells. MATERIALS: To explore the actions of IL-21 with other gammac-dependent cytokines in alloreactivity, mRNA expression of IL-21, IL-21R alpha-chain, and IL-2 proliferation and cytotoxicity was measured after stimulation in mixed lymphocyte reactions. Additionally, IL-21 and IL-21R alpha-chain expression was studied in biopsies of heart transplant patients. RESULTS: Analysis of mRNA expression levels of allostimulated T-cells showed a 10-fold induction of IL-21 and IL-21R alpha-chain. Interestingly, induction of IL-21 was highly dependent on IL-2 (as in the presence of anti-IL-2, anti-IL-2R alpha-chain, and the immunosuppressive drugs cyclosporine A, tacrolimus, and rapamycin) the transcription of IL-21 was almost completely inhibited, whereas in the presence of exogenous IL-2 the mRNA expression of IL-21 was even more upregulated. IL-21 functioned as a costimulator for IL-2 to augment proliferation and cytotoxic responses, while blockade of the IL-2 route abrogated these functions of IL-21. Blockade of the IL-21 route by anti-IL-21R alpha-chain monoclonal antibodies inhibited the proliferation of alloactivated T-cells. Also, in vivo alloreactivity was associated with IL-21/IL-21R alpha-chain expression. After heart transplantation, the highest intragraft IL-21, IL-21R alpha-chain, and IL-2 mRNA expression levels were measured during acute rejection (P<0.001, P=0.01, P=0.03). CONCLUSION:IL-21 is a critical cytokine for IL-2 dependent immune processes. Blockade of the IL-21 pathway may provide a new perspective for the treatment of allogeneic responses in patients after transplantation.
Authors: Girdhari Lal; Neeraja Kulkarni; Yumi Nakayama; Amit K Singh; Apoorva Sethi; Bryna E Burrell; C Colin Brinkman; Daiki Iwami; Tianshu Zhang; Thomas Hehlgans; Jonathan S Bromberg Journal: Immunol Lett Date: 2016-01-06 Impact factor: 3.685
Authors: R C Starling; J Stehlik; D A Baran; B Armstrong; J R Stone; D Ikle; Y Morrison; N D Bridges; P Putheti; T B Strom; M Bhasin; I Guleria; A Chandraker; M Sayegh; K P Daly; D M Briscoe; P S Heeger Journal: Am J Transplant Date: 2015-08-10 Impact factor: 8.086
Authors: Helen M McGuire; Stacey Walters; Alexis Vogelzang; Carol M Y Lee; Kylie E Webster; Jonathan Sprent; Daniel Christ; Shane Grey; Cecile King Journal: Diabetes Date: 2011-03 Impact factor: 9.461
Authors: Alessandra Petrelli; Michele Carvello; Andrea Vergani; Kang Mi Lee; Sara Tezza; Ming Du; Sonja Kleffel; Liu Chengwen; Bechara G Mfarrej; Patrick Hwu; Antonio Secchi; Warren J Leonard; Deborah Young; Mohamed H Sayegh; James F Markmann; Allan J Zajac; Paolo Fiorina Journal: Diabetes Date: 2011-10-19 Impact factor: 9.461
Authors: Kitty de Leur; Franka Luk; Thierry P P van den Bosch; Marjolein Dieterich; Luc J W van der Laan; Rudi W Hendriks; Marian C Clahsen-van Groningen; Fadi Issa; Carla C Baan; Martin J Hoogduijn Journal: Transplantation Date: 2019-10 Impact factor: 5.385
Authors: Benjamin D S Clarkson; Changying Ling; Yejie Shi; Melissa G Harris; Aditya Rayasam; Dandan Sun; M Shahriar Salamat; Vijay Kuchroo; John D Lambris; Matyas Sandor; Zsuzsanna Fabry Journal: J Exp Med Date: 2014-03-10 Impact factor: 14.307
Authors: Aleixandra Mendoza Rojas; Teun van Gelder; Ronella de Kuiper; Derek Reijerkerk; Marian C Clahsen-van Groningen; Dennis A Hesselink; Carla C Baan; Nicole M van Besouw Journal: Sci Rep Date: 2021-06-14 Impact factor: 4.379
Authors: Yongkang Wu; Nicole M van Besouw; Yunying Shi; Martin J Hoogduijn; Lanlan Wang; Carla C Baan Journal: Front Immunol Date: 2016-08-23 Impact factor: 7.561